Douglas E. Paull, MD, MS and Paul N. Uhlig, MD, MPA
Risk managers can help patient-subjects and clinician-researchers make informed novel device implantation decisions in the absence of preclinical trial data.
AMA J Ethics. 2020;22(11):E911-918. doi:
10.1001/amajethics.2020.911.
An ethical case explores genetic screening and whether or not sharing test results with patients only, and not other family members who may be at risk, is sufficient.
Physicians need to be aware of the legal and ethical issues raised by genetic information and technology, as evidenced by three court rulings dealing with prenatal testing and a family predisposition to genetic genetically transferred illness.